Chinese Traditional and Herbal Drugs
|
2025, 56(3): 819-830
Self-assembled phosphatidylcholine/chitosan nanoparticles loaded with hyperoside: Preparation, characterization and oral pharmacokinetics<
Full
LIU Yanju1, WU Yuedan1, WEI Xiaojie1, FANG Yuxin1, LI Juequan2, JUE Lili1, FAN Mingsong3
Affiliations
1 Zhengzhou University of Industrial Technology, Zhengzhou 451100, China;
2 Shanghai Leiyunshang Pharmaceutical Co., Ltd., Shanghai 201401, China;
3 Heilongjiang Chun Lok Pharmaceutical Co., Ltd., Jixi 158100, China
doi: 10.7501/j.issn.0253-2670.2025.03.009
Outline
Objective To prepare hyperoside self-assembled phosphatidylcholine chitosan nanoparticles (Hyp-PC/CS-NPs), and relative oral bioavailability were studied. Methods The main influencing factors of Hyp-PC/CS-NPs were investigated by single factor experiments, Box-Behnken design-response surface method was employed to optimize prescriptions of Hyp-PC/CS-NPs. Transmission electron microscope (TEM) was employed to observe microscopic appearance of Hyp-PC/CS-NPs, lyophilized powder of Hyp-PC/CS-NPs was prepared and its saturated solubility was determined, Fourier transform infrared spectroscopy (FTIR) was used to investigate the binding mechanism of Hyp-PC/CS-NPs lyophilized powder and each component, and crystal form of hyperoside was analyzed by X-ray powder diffraction (XRPD). Drug release behavior in vitro of Hyp-PC/CS-NPs lyophilized powder and hyperoside was determined, the sedimentation rate of Hyp-PC/CS-NPs lyophilized powder was determined and its storage stability was also investigated. SD rats were administered intragastrically with hyperoside and Hyp-PC/CS-NPs lyophilized powder, its oral pharmacokinetic behavior was studied, and relative oral bioavailability of Hyp-PC/CS-NPs was calculated. Results Optimal formulations of Hyp-PC/CS-NPs: hyperoside concentration was 0.37 mg/mL, phosphatidylcholine to chitosan ratio was 16.3:1, phosphatidylcholine to hyperoside ratio was 7.9:1. Envelopment efficiency, drug loading, particle size and ζ potential were (84.19 ±1.23)%, (8.81 ±0.16)%, (166.18 ±4.03) nm and (32.39 ±0.95) mV, respectively. Appearance of Hyp-PC/CS-NPs was spherical, hyperoside may have complexed with the carrier by hydrogen bond. The state of hyperoside changed into an amorphous form in Hyp-PC/CS-NPs freeze-dried powder. Solubility of hyperoside in simulated gastric juice, distilled water and simulated intestinal juice was increased by 7.22, 4.04 and 5.10 times, respectively. Pharmacokinetic results showed that the pharmacokinetic parameters of Hyp-PC/CS-NPs were significantly increased compared with hyperoside or physical mixture (P < 0.01), and the relative bioavailability of hyperoside in Hyp-PC/CS-NPs was increased to 4.11 times. Conclusion Hyp-PC/CS-NPs and its lyophilized powder were successfully prepared, pharmacokinetic behavior of hyperoside in vivo was greatly changed, and bioavailability of hyperoside was significantly increased by Hyp-PC/CS-NPs, which established the experimental foundation for the follow-up pharmacodynamic evaluation.
hyperoside
/
self-assembled nanoparticles
/
phosphatidylcholine
/
chitosan
/
bioavailability
/
pharmacokinetics
/
Box-Behnken design-response surface method
刘艳菊, 武月丹, 位小杰, 方雨欣, 李珏泉, 决利利, 范明松.
包载金丝桃苷的磷脂酰胆碱/壳聚糖自组装纳米粒的制备、表征及其口服药动学研究.
中草药,
2025
, 56
(3)
: 819
-830
.
DOI: 10.7501/j.issn.0253-2670.2025.03.009
LIU Yanju, WU Yuedan, WEI Xiaojie, FANG Yuxin, LI Juequan, JUE Lili, FAN Mingsong.
Self-assembled phosphatidylcholine/chitosan nanoparticles loaded with hyperoside: Preparation, characterization and oral pharmacokinetics<[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(3)
: 819
-830
.
DOI: 10.7501/j.issn.0253-2670.2025.03.009
Year 2025 volume 56 Issue 3
51
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.03.009
- Receive Date:2024-08-16
- Online Date:2026-11-13